Assessment of the Post-Marketing “Drug Ineffective” Reports Received by the Saudi Vigilance System
Hana Jaffar Al Khabbaz, Talal A. Alsoaiby & Rayan I. Alolayet · Journal of Pharmaceutical Research International · 2023
Aim: Drug Ineffective (DI) reports are Adverse Drug Events (ADE) important for post-marketing surveillance (PMS). Currently drug safety information from the DI reports received by the Saudi Food and Drug Authority (SFDA) via the Saudi Vigilance System (SVS) is undetermined. The...
Open access
Research Article
10.9734/jpri/2023/v35i307461